Smith, Joshua R. http://orcid.org/0000-0001-7008-165X
DiSalvo, Maura
Green, Allison
Ceranoglu, Tolga Atilla http://orcid.org/0000-0002-7327-5502
Anteraper, Sheeba Arnold
Croarkin, Paul http://orcid.org/0000-0001-6843-6503
Joshi, Gagan
Funding for this research was provided by:
National Institute of Mental Health (T32HD007475)
Alan and Lorraine Bressler Clinical and Research Program for Autism Spectrum Disorder
National Institute of Mental Health (K23MH100450, 1R03MH121879-01A1, R01 MH113700, R01 MH124655)
Article History
Received: 1 November 2021
Accepted: 31 August 2022
First Online: 26 September 2022
Declarations
:
: Not applicable.
: All authors provide consent for publication.
: JRS is employed by Vanderbilt University Medical Center as a child and adolescent psychiatrist with no other financial relationships to disclose. AG and MD do not have financial relationships to disclose<b>.</b> AC reports personal fees from Massachusetts Department of Mental Health, non-financial support from NIH, personal fees from Pamlab, Inc., personal fees from US Department of Defense, non-financial support from Neurocentria, Inc., personal fees from Food and Drug Administration, non-financial support from Pfizer Pharmaceuticals, Inc., personal fees from Sunovion Pharmaceuticals, Inc., non-financial support from Roche TCRC, Inc. SA is employed by the Carle Foundation Hospital in Urbana, Illinois with no other financial relationships to disclose. PC has received research support from Pfizer, Inc. and equipment support from Neuronetics, Inc. and MagVenture, Inc. He has received grant in kind support from AssureRX for supplies and genotyping. He has been the primary investigator for a multicenter study funded by Neuronetics, Inc. and a site primary investigator for a study funded by NeoSync, Inc. He has served as a paid consultant for Engrail Therapeutics, Myriad Neuroscience, Procter and Gamble Company, and Sunovion. In the last year, GJ has received research support from the Demarest Lloyd, Jr. Foundation as a primary investigator (PI) for investigator-initiated studies. Additionally, GJ receives research support F. Hoffmann-La Roche Ltd. as a site PI for multi-site trials. In the past three years, GJ has received research support from Pfizer and the Simons Center for the Social Brain. In addition, GJ has received honorarium from the Governor's Council for Medical Research and Treatment of Autism in New Jersey and from NIMH for grant review activities. Finally, he received speaker’s honorariums from the American Academy of Child and Adolescent Psychiatry, The Israeli Society of ADHD, the Canadian Academy of Child and Adolescent Psychiatry, and the University of Jülich.